These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34942964)

  • 1. The Role of NRF2 in Mycobacterial Infection.
    Matsuyama M; Nonaka M; Nakajima M; Morishima Y; Ishii Y; Hizawa N
    Antioxidants (Basel); 2021 Nov; 10(12):. PubMed ID: 34942964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 Regulates Granuloma Formation and Macrophage Activation during Mycobacterium avium Infection via Mediating Nramp1 and HO-1 Expressions.
    Nakajima M; Matsuyama M; Kawaguchi M; Kiwamoto T; Matsuno Y; Morishima Y; Yoshida K; Sherpa M; Yazaki K; Osawa H; Muratani M; Ishii Y; Hizawa N
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.
    Yoon HJ; Choi HY; Ki M
    BMC Infect Dis; 2017 Jun; 17(1):432. PubMed ID: 28619015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and clinical characteristic of mycobacterial infections in human immunodeficiency virus-infected patients in Siriraj Hospital.
    Chayakulkeeree M; Naksanguan T
    J Med Assoc Thai; 2015 Mar; 98(3):238-44. PubMed ID: 25920293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of nuclear factor, erythroid 2-like 2-mediated genes differentiates tuberculosis.
    Qian Z; Lv J; Kelly GT; Wang H; Zhang X; Gu W; Yin X; Wang T; Zhou T
    Tuberculosis (Edinb); 2016 Jul; 99():56-62. PubMed ID: 27450006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK Cell-Derived IFN-γ Protects against Nontuberculous Mycobacterial Lung Infection.
    Lai HC; Chang CJ; Lin CS; Wu TR; Hsu YJ; Wu TS; Lu JJ; Martel J; Ojcius DM; Ku CL; Young JD; Lu CC
    J Immunol; 2018 Sep; 201(5):1478-1490. PubMed ID: 30061197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of purified protein derivative mycobacterial skin test antigens in children and adolescents: purified protein derivative skin test results correlated with mycobacterial isolates.
    Margileth AM
    Pediatr Infect Dis; 1983; 2(3):225-31. PubMed ID: 6408620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review.
    Brode SK; Daley CL; Marras TK
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1370-7. PubMed ID: 25299873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontuberculous mycobacterial species and
    Mertaniasih NM; Kusumaningrum D; Koendhori EB; ; Kusmiati T; Dewi DN
    Int J Mycobacteriol; 2017; 6(1):9-13. PubMed ID: 28317798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.
    Yang C; Luo X; Fan L; Sha W; Xiao H; Cui H
    Front Cell Infect Microbiol; 2020; 10():571230. PubMed ID: 33680977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the incidence between tuberculosis and nontuberculous mycobacterial disease after gastrectomy.
    Kim CH; Im KH; Yoo SS; Lee SY; Cha SI; Jung HY; Park JY; Yu W; Lee J
    Infection; 2014 Aug; 42(4):697-704. PubMed ID: 24817438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.